Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Eyüpoglu, Ilker Y ^a   Hore, Nirjhar ^a   Savaskan, Nic E ^a   Grummich, Peter ^a   Roessler, Karl ^a   Buchfelder, Michael ^a   Ganslandt, Oliver ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ANAPLASTIC GLIOMA; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE GUIDED SURGERY; FLUOROSCOPY; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTEGRATED FUNCTIONAL NEURONAVIGATION; INTERMETHOD COMPARISON; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MALE; MINIMAL RESIDUAL DISEASE; NEUROLOGIC DISEASE; NEURONAVIGATION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PATIENT SAFETY; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE;

ADULT; AGED; AMINOLEVULINIC ACID; BRAIN; BRAIN NEOPLASMS; FEMALE; FLUORESCENT DYES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM, RESIDUAL; NEURONAVIGATION;

EID: 84866852737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044885     Document Type: Article

References (36)

1. Wen PY, Kesari S, (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
3. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, et al. (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13: 1339-1348.
4. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, et al. (2011) Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12: 1062-1070.
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
6. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, et al. (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83: 588-593.
7. Wick W, Steinbach JP, Kuker WM, Dichgans J, Bamberg M, et al. (2004) One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology 62: 2113-2115.
8. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, et al. (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99: 467-473.
9. van den Bent MJ, Hegi ME, Stupp R, (2006) Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 42: 582-588.
10. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, et al. (1997) Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41: 1028-1036; discussion 1036-1028.
11. Kreth FW, Berlis A, Spiropoulou V, Faist M, Scheremet R, et al. (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86: 2117-2123.
12. Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, et al. (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102: 105-113.
13. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S, (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45-60; discussion 60-41.
14. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, et al. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95: 190-198.
15. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ, (1990) The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53: 466-471.
16. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, et al. (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65: 463-469; discussion 469-470.
17. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7: 392-401.
18. Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, et al. (2011) Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosurg 76: 120-127.
19. Liao H, Shimaya K, Wang K, Maruyama T, Noguchi M, et al. (2008) Combination of intraoperative 5-aminolevulinic acid-induced fluorescence and 3-D MR imaging for guidance of robotic laser ablation for precision neurosurgery. Med Image Comput Comput Assist Interv 11: 373-380.
20. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, et al. (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42: 1044-1055; discussion 1055-1046.
21. Kleihues P, Cavenee WK (2000) Tumours of the Nervous System; Kleihues P, Sobin LH, editors. Lyon: IARC Press. 314 p.
22. Buckner JC, (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30: 10-14.
23. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, et al. (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62: 564-576; discussion 564-576.
24. Nimsky C, Ganslandt O, Fahlbusch R, (2004) Functional neuronavigation and intraoperative MRI. Adv Tech Stand Neurosurg 29: 229-263.
25. Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R, (2004) Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery 55: 358-370; discussion 370-351.
26. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R, (2006) Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res 28: 482-487.
27. Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, et al. (2010) Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 113: 352-357.
28. Stepp H, Beck T, Pongratz T, Meinel T, Kreth FW, et al. (2007) ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. J Environ Pathol Toxicol Oncol 26: 157-164.
29. Roberts DW, Valdes PA, Harris BT, Fontaine KM, Hartov A, et al. (2010) Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. J Neurosurg.
30. De Witt Hamer PC, Gil Robles S, Zwinderman AH, Duffau H, Berger MS, (2012) Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis. J Clin Oncol.
31. Chang EF, Clark A, Smith JS, Polley MY, Chang SM, et al. (2011) Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg 114: 566-573.
32. Sanai N, Berger MS, (2010) Intraoperative stimulation techniques for functional pathway preservation and glioma resection. Neurosurg Focus 28: E1.
33. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466.
34. Stummer W, Tonn JC, Mehdorn HM, Nestler U, Franz K, et al. (2010) Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg.
35. Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J, (2003) Debulking or biopsy of malignant glioma in elderly people- a randomised study. Acta Neurochir (Wien) 145: 5-10.
36. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, et al. (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93: 1003-1013.